Purpose-Sampling of arterial blood for metabolite correction is often required to define a true radiotracer input function in quantitative modeling of PET data. However, arterial puncture for blood sampling is often undesirable. To establish whether venous blood could substitute for arterial blood in metabolite analysis for quantitative PET studies with 1-[ 11 C]acetate and 1-[ 11 C]palmitate, we compared the results of [ 11 C]CO 2 -metabolite analyses performed on simultaneously collected arterial and venous blood samples.
Introduction
Simple carboxylic acids radiolabeled with carbon-11 (t 1/2 : 20.4 min), especially [ 11 C]acetate and [ 11 C]palmitate, have been used widely as tools for imaging with positron emission tomography (PET) to evaluate the rate at which their endogenous counterparts are being oxidatively metabolized by myocardium under various physiological conditions. One of the major radiolabeled metabolites produced by these compounds is [ 11 C]CO 2 , a product of the tricarboxylic acid cycle. Models for quantification of myocardial metabolic rate from the resulting PET data require knowledge of both the concentration of radioactivity in myocardium as a function of time, as well as knowledge of the concentration of radiopharmaceutical in the arterial blood supplying that tissue. While the PET images readily quantify radioactivity in the myocardium, as well as the arterial blood radioactivity (based on a region of interest in the cavity of the left ventricle or left atrium), those PET data simply define regional radionuclide concentrations without information on the chemical form of the radionuclide. Thus, for tracer kinetic modeling to quantify metabolic rates, it is necessary to independently measure the fraction of total blood 11 C activity present in blood as [ 11 C]CO 2 to generate a correct radiopharmaceutical arterial input function.
The technique most commonly used to determine the radiolabeled CO 2 concentration of blood is simplein vitro acidification of a blood sample, followed by purging with an inert gas to drive off CO 2 . The fraction of total blood 11 C activity that remains after the gas purge represents 11 C species other than 11 CO 2 . This method has been used in a number of preclinical and clinical PET studies yielding important insights into myocardial metabolism. Here we report experimental validation of the selectivity of the gas-purge technique for removing 11 CO 2 from blood. Since direct arterial cannulation for blood sampling is invasive, painful, and can result in undesirable complications, we have then applied this analytical method to assess whether arterial blood [ 11 C]CO 2 concentrations following administration of [ 11 C]acetate and [ 11 C]palmitate can be accurately, and less invasively, estimated by the [ 11 C]CO 2 levels of venous blood.
Materials and Methods

General
The C]CO 2 gas in a 2 mL sodium hydroxide (100mM) solution. The resultant sodium 11 Cbicarbonate solution was then mixed with 3 mL of saline. The final solution contained 10-15 mCi/mL (370-555 MBq/mL). Theheparanized blood samples used for the air purge validation study were taken from the arterial line of swineprior to initiation of planned PET studies. Heparinized blood samples for the arterial-venous comparison study were obtained from four mature miniature pigs (male; ∼25kg) at specified times after sequential injection of 1-[ 11 C]acetate and 1-[ 11 C]palmitate(allowing ∼90-minutes between injections for decay of the prior dose). Arterial blood samples were drawn from the carotid artery, while venous blood was sampled from the jugular vein. The pigs were anesthetized with 1-3% isoflurane and mechanically ventilated throughout the period of the study. The protocol for the animal studies was approved by the Indiana University Animal Care and Use Committee. Radioactivity measurements were made by dose calibrator or NaI(Tl) automatic gamma counter (Beckman Gamma 8000).
Validation of protocol for the determination of [ 11 C]CO 2 in blood
Radioactive sample handling was carried out behind lead-shielding in a chemical fume hood. A 50-100 μCi sample (20-100 μL) of aqueous [ 11 C]CO 2 or [ 11 C]acetate or [ 11 C]palmitate/HSA was added to 3 mL of blood in vitro and gently mixed. A 1 mL aliquot of the blood was then transferred to a counting vial containing 1 mL sodium hydroxide(0.1 N) and 3 mL isopropanol, which was then immediately capped to retain any 11 CO 2 as bicarbonate. This base-treated blood contained all 11 C radioactivity (vial A). A second 1 mL aliquot of the blood containing radiotracer was added to a counting vial containing 1 mL sodium bicarbonate (0.5 N) and 3 mL isopropanol, and the mixture was vortex mixed. Then, 1 mL 6N hydrochloric acid was added followed by 10-20 secondsof vortex mixing. Next, the acid-treated blood sample was purged with air,bubbled into the blood via a 4-inch flexible filter straw (B Braun Medical, Inc., Bethlehem, PA), for 10 and 15 minutes to drive off the 11 CO 2 (vial B). The activity remaining in "vial B" represents for total non-11 CO 2 radioactivity. After decay correction of the radioactivity measurements to a common time point, the percentage of total radioactivity released as 11 CO 2 was calculated as: administration of 1-[ 11 C]acetate (32.2±3.5 mCi; 1.19±0.1 GBq; n=4) or 1-[ 11 C]palmitate (27.5±5.4 mCi;1.0±0.2 GBq; n=4). For each time point, a 1 mL aliquot of the blood was transferred to a counting vial containing 1 mL 0.1 N sodium hydroxide and 3 mL isopropanol, and then immediately capped to retain any 11 CO 2 as bicarbonate (vial A). A second 1 mL aliquot of each blood sample was added to a counting vial containing 1 mL of 0.5 N sodium bicarbonate and 3 mL isopropanol. Then, 1 mL of 6N hydrochloric acid was added, and the acid-treated blood was vortex mixed.The mixture was then bubbled with air for 10 minutes to release 11 CO 2 (vial B). The 11 C radioactivity in each vial was then measured with an automatic gamma counter, and after decay correction to a common time point, the fraction of total blood 11 C present as [ 11 C]CO 2 was calculated as:
Analysis of blood 11 CO2 after [ 11 C] acetate administration to humans
In conjunction with an IRB-approved study of [ 11 C]acetate PET imaging in humans, the levels of [ 11 C]CO 2 were also determined in peripheral venous human blood samples. The blood was drawn from a forearm vein into heparinized syringes at 1, 3, 6, 8, 10, 15, 20, 25 and 30 min (2-3 mL each) following i.v. administration of 1-[ 11 C]acetate (876.9±140.6 MBq;3 men and 3 women) and immediately analyzed following the procedures described above.
Results and Discussion
To verify the suitability of the gas purge method for the determining the level of bloodborne [ 11 C]CO 2 , analysis was carried out after directly mixing [ 11 C]CO 2 with whole blood in vitro. After acidification and air bubbling through the sample for 10-minutes, more than 99% of the 11 C was released from the [ 11 C]CO 2 -spiked whole blood ( Table 1) . Continuation of the gas purge for an additional 5-minutes did not appreciably alter the residual blood 11 C level. As expected, blood samples similarly spiked with [ 11 C]acetate or [ 11 C]palmitate showed no loss of radioactivity, even after 15 min of air purging (Table 1) . These results are similar to previous reported findings, where 95% of [ 11 C]acetate was retained, and 98% of [ 11 C]-labeled bicarbonate was eliminated, in acid-treated blood samples after 10-minutes of inert gas bubbling. This validation study confirmed that the gas purge method was quite effective for selectively releasing [ 11 C]CO 2 from acid-treated whole blood. Additionally, the analysis method is technically straightforward, simple to implement, and can readily be completed on a time frame compatible with the 20-minute 11 C half-life.
To evaluate whether venous blood sampling might reliably substitute for arterial blood sampling as this method is translated to support quantitative PET studies of acetate and palmitate metabolism in humans, we wanted to examine the correlation between arterial and venous blood [ 11 C]CO 2 concentrations after i.v. administration of [ 11 C]acetate or [ 11 C]palmitate. The kinetic models for quantification of tissue metabolism with [ 11 C]acetate and [ 11 C]palmitate require knowledge of the true tracer arterial blood time-activity curve, but direct arterial cannulation for blood sampling is undesirably invasive in human studies.
Reliance solely on the PET data for quantification of the total arterial blood level of radioactivity, coupled with venous blood sampling for metabolite analysis, is far more practical to implement in clinical studies. But, this latter approach is only valid if venous blood can be demonstrated to be a reasonable surrogate for quantifying the relative levels of parent tracer and metabolite(s) in arterial blood. An excellent correlation was found between the arterial and venous blood [ 11 C]CO 2 concentrations at all times following [ 11 C]acetate injection, with a correlation coefficient, r 2 =0.97 (n=34 pairs; Fig. 1A ). For 11 C-palmitate, there is also a good correlation between the measured fractions of radioactivity present as [ 11 C]CO 2 in arterial and venous blood (r 2 = 0.9;n=26 pairs; Fig. 1B ). Over the 1-30 minute period, the fraction of total blood 11 C present as 11 CO 2 rose from 4% to 64% for acetate, and from 0% to 24% for palmitate (Fig. 2) . However, comparing [ 11 C]acetate to [ 11 C]palmitate, there is a marked difference in the rates at which total blood radioactivity comes to be dominated by the [ 11 C]CO 2 metabolite.
The concordance of the metabolite data for these paired venous and arterial blood samples has a significant impact on imaging study design. For PET studies to quantify the rates of tissue metabolism of [ 11 C]acetate and/or [ 11 C]palmitate, venous blood sampling will be adequate for determining the [ 11 C]CO 2 metabolite correction required in an image-derived arterial blood 11 C time-activity curve. Since 11 CO 2 is exhaled, the simple mass balance obviously requires that arterial blood have a lower 11 CO 2 concentration than the venous blood entering the lungs (Fig.3) . Our results, however, indicate the fractional loss of 11 CO 2 from the labeled blood pool of CO 2 /H 2 CO 3 is sufficiently small that blood samples from the vein remain a reasonable surrogate for defining the arterial blood level of the [ 11 C]CO 2 metabolite after administration of 1-[ 11 C]acetate and 1-[ 11 C]palmitate.
Arterial blood time-radioactivity curves showed similarly rapid clearance of both 1-[ 11 C]acetate and 1-[ 11 C]palmitate (Fig. 4) . In the myocardium, [ 11 C]acetate is converted to acetyl-CoA, and immediately enters the tricarboxylic acid cycle, where radioactive CO 2 is produced as its end product. The fraction of blood 11 C present as [ 11 C]CO 2 in arterial/ venous increased over time steadily, with the absolute [ 11 C]CO 2 concentration reaching a peak at about 10-15 min post injection, and then remaining stable until the end of imaging at 30 minutes. As shown in Figure 2A , by 15 minutes after [ 11 C]acetate administration, approximately 60-70% of the blood radioactivity was labeled bicarbonate, with the radioactivity of 11 CO 2 /HCO 3 -contributing significantly to the blood radioactivity at even a few minutes post-radiopharmaceutical administration. These results are consistent with previous studies.
In the case of [ 11 C]palmitate, approximately 25-30% of the blood radioactivity was present as 11 CO 2 at 20 min post-administration ( Fig. 2A ). This result is also similar to previously reported findings. Unlike 1-[ 11 C]acetate, the 16-carbon 1-[ 11 C]palmitate has a more complicated biochemical fate. Some of the 1-[ 11 C]palmitate undergoes β-oxidation, where a 2-C fragment is released as acetyl-CoA and enters the citric acid cycle for complete oxidation. On the other hand, some of the 1-[ 11 C]palmitate administrated may not undergo immediate oxidation, but instead be stored as triglyceride.
For comparison with the findings in the pig model, the levels of 11 CO 2 in venous blood were also measured in six human subjects after intravenous administration of 1-[ 11 C]acetate (Fig.  2B) . The rate at which human blood radioactivity becomes predominantly 11 CO 2 is very similar to the findings in the pig model.
Conclusions
The 10-minute gas purge method is quite reliable for removing 11 CO 2 from blood. In modeling to quantify the rate of tissue oxidative metabolism using [ 11 C]acetate and [ 11 C]palmitate, [ 11 C]CO 2 levels measured in venous blood appear suitable as a surrogate for quantifying the metabolite contribution to total 11 C-radioactivity in arterial blood. Fractions of arterial and venous total blood radioactivity present as 11 CO 2 following i.v. administration of [ 11 C]acetate and [ 11 C]palmitate to miniaturepig (A; n =4), and human (B; n = 6).In pig, the percentage of 11 CO 2 rose from 4% to 64% for acetate, and 0% to 24% for palmitate, over a 30-minute period following the i.v administration of the indicated tracer. Representative normalized decay-corrected arterial blood time-radioactivity curves obtained from a single pig by direct measurement of 11 C radioactivity in sampled arterial blood. The Table 1 Effectiveness of the gas-purge method for selectively removing [ 11 C]CO 2 from acidified whole blood. 
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